title: tmRNA decreases the bactericidal activity of aminoglycosides and the susceptibility to inhibitors of cell wall synthesis.
abstract: Trans-translation is a process that recycles ribosomes stalled on problematic mRNAs. tmRNA, coded by the DeltassrA gene, is a major component of trans-translation. Bacteria lacking tmRNA are more sensitive to several inhibitors of protein synthesis when compared to a wild type strain. We measured bacterial growth of the DeltassrA and wild type strains in Escherichia coli in the presence of 14 antibiotics including some that do not target protein synthesis. Both the optical density of the bacterial cultures and the number of viable cells were monitored. For the ribosome-targeted antibiotics, sensitization was observed on erythromycin, chloramphenicol, kanamycin, puromycin and streptomycin. Minor or no effects were observed with clindamycin, tetracycline and spectinomycin. Surprisingly, the DeltassrA strain is more sensitive than wild type to inhibitors of cell wall synthesis: fosfomycin and ampicillin. No growth difference was observed on drugs with other target sites: ofloxacin, norfloxacin, rifampicin and trimethoprim. Sensitization to antibiotics having target sites other than the ribosome suggests that trans-translation could influence antibiotic-induced stress responses. In trans-translation-deficient bacteria, cell death is significantly enhanced by the two aminoglycosides that induce translational misreading, streptomycin and kanamycin.
authors.affiliation: Institute of Technology, University of Tartu, Tartu, Estonia.
authors.forename: Hannes
authors.initials: H
authors.lastname: Luidalepp
authors.forename: Marc
authors.initials: M
authors.lastname: Hallier
authors.forename: Brice
authors.initials: B
authors.lastname: Felden
authors.forename: Tanel
authors.initials: T
authors.lastname: Tenson
mesh_terms: D000617:Aminoglycosides / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D049109:Cell Proliferation; D002473:Cell Wall / Q000187:drug effects* / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D050296:Microbial Viability / Q000187:drug effects; D014176:Protein Biosynthesis / Q000187:drug effects*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012329:RNA, Bacterial / Q000502:physiology*
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D011500:Protein Synthesis Inhibitors; D012329:RNA, Bacterial; C096222:tmRNA